| http://dbpedia.org/ontology/abstract
|
Medicago Inc. je soukromá kanadská biotech … Medicago Inc. je soukromá kanadská biotechnologická firma, založená v roce 1999. Zaměřuje se na výzkum, vývoj a komerční nasazení částic podobných virům za využití rostlin jako bioreaktorů. Účelem je produkce bílkovin pro vakcíny a léčiva. Cílem společnosti je tvorba technologie pro rychlou a vysokovýtěžnou produkci svých kandidátních účinných látek; za tímto účelem používají australskou rostlinu , blízce příbuznou tabáku. Hlavními medicínskými cíli jsou antivirové vakcíny a léky založené na protilátkách. Firma vyvíjí vakcínu Medicago-GlaxoSmithKline proti covidu-19 (CoVLP).o-GlaxoSmithKline proti covidu-19 (CoVLP).
, Medicago Inc. adalah sebuah perusahaan bio … Medicago Inc. adalah sebuah perusahaan bioteknologi Kanada yang berfokus pada penemuan, pengembangan dan komersialisasi partikel- menggunakan tumbuhan sebagai "bioreaktor" untuk menghasilkan protein sebagai kandidat vaksin dan medikasi. Medicago menumbuhkan partikel-partikel mirip virusnya pada rumput Australia, .el mirip virusnya pada rumput Australia, .
, Medicago Inc. is a privately-owned Canadia … Medicago Inc. is a privately-owned Canadian biotechnology company focused on the discovery, development, and commercialization of virus-like particles using plants as bioreactors to produce proteins, candidate vaccines, and medications. By using live plant leaves as hosts in the discovery and manufacturing process, the Medicago "Proficia" technology has the goal to create a rapid, high-yield system for its product candidates. The main clinical targets for Medicago product candidates in 2020 are antiviral vaccines and antibody therapeutics. The company has a Phase III clinical trial underway in 2020 for its candidate to prevent seasonal influenza. Medicago grows its virus-like particles in the Australian weed, Nicotiana benthamiana. In July 2020, the company began a Phase I clinical trial on its candidate vaccine for COVID-19 disease, coVLP, which advanced to a large Phase II-III trial in Canada and the United States during November 2020. In December 2021, the company announced that its CoVLP vaccine candidate exhibited 71% efficacy and no adverse effects in a multinational, Phase III clinical trial. In February 2022, Health Canada authorized use of CoVLP (brand name Covifenz) for preventing COVID-19 infection in adults 18 to 64 years old. The company's name is derived from the Latin word for alfalfa, which was the first plant the company used to develop its technologies. Medicago technologies evolved from research at the Laval University and Agriculture and Agri-Food Canada in the 1990s.culture and Agri-Food Canada in the 1990s.
, Medicago est une société biopharmaceutique … Medicago est une société biopharmaceutique basée à Québec qui se concentre sur la découverte, le développement et la commercialisation des particules pseudo-virales utilisant le Nicotiana benthamiana, comme bioréacteur pour produire des protéines comme vaccins et médicaments candidats. Medicago a été acquise par la société japonaise (en) en 2013.ise par la société japonaise (en) en 2013.
|
| http://dbpedia.org/ontology/foundingYear
|
1999
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Canada +
, http://dbpedia.org/resource/Quebec_City +
, http://dbpedia.org/resource/Quebec +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Medicago_logo.svg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Privately_held_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://medicago.com/en/%7Cmedicago.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
64731000
|
| http://dbpedia.org/ontology/wikiPageLength
|
14416
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1122236180
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Microgram +
, http://dbpedia.org/resource/Brand +
, http://dbpedia.org/resource/Chicken_as_biological_research_model +
, http://dbpedia.org/resource/Alfalfa +
, http://dbpedia.org/resource/CoVLP +
, http://dbpedia.org/resource/Category:Canadian_companies_established_in_1999 +
, http://dbpedia.org/resource/Category:Privately_held_companies_of_Canada +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/Government_of_Canada +
, http://dbpedia.org/resource/Antigen +
, http://dbpedia.org/resource/Vaccine +
, http://dbpedia.org/resource/Immune_system +
, http://dbpedia.org/resource/Coronavirus +
, http://dbpedia.org/resource/Nicotiana_benthamiana +
, http://dbpedia.org/resource/World_Health_Organization +
, http://dbpedia.org/resource/Category:COVID-19_vaccine_producers +
, http://dbpedia.org/resource/Category:1999_establishments_in_Quebec +
, http://dbpedia.org/resource/Health_Canada +
, http://dbpedia.org/resource/Adjuvant +
, http://dbpedia.org/resource/In_vivo +
, http://dbpedia.org/resource/Immune_response +
, http://dbpedia.org/resource/Canada +
, http://dbpedia.org/resource/United_Nations +
, http://dbpedia.org/resource/COVID-19_vaccine +
, http://dbpedia.org/resource/Antiviral +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Agriculture_and_Agri-Food_Canada +
, http://dbpedia.org/resource/Mutation +
, http://dbpedia.org/resource/Coronavirus_disease_2019 +
, http://dbpedia.org/resource/Protein_production +
, http://dbpedia.org/resource/Quebec_City +
, http://dbpedia.org/resource/Covifenz +
, http://dbpedia.org/resource/File:Nicotiana_benthamiana_plant.jpg +
, http://dbpedia.org/resource/File:Nicotiana_benthamiana_leaf.jpg +
, http://dbpedia.org/resource/File:Medicago_logo.svg +
, http://dbpedia.org/resource/Philip_Morris_International +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Medication +
, http://dbpedia.org/resource/Adverse_effect +
, http://dbpedia.org/resource/Seasonal_influenza +
, http://dbpedia.org/resource/Universit%C3%A9_Laval +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Canada +
, http://dbpedia.org/resource/Phillip_Morris_International +
, http://dbpedia.org/resource/Bioreactor +
, http://dbpedia.org/resource/Incubator_%28culture%29 +
, http://dbpedia.org/resource/Category:Companies_based_in_Quebec_City +
, http://dbpedia.org/resource/Extract +
, http://dbpedia.org/resource/Influenza +
, http://dbpedia.org/resource/Category:Specialty_drugs +
, http://dbpedia.org/resource/Latin +
, http://dbpedia.org/resource/2009_flu_pandemic_vaccine +
, http://dbpedia.org/resource/Virus-like_particle +
, http://dbpedia.org/resource/Mitsubishi_Tanabe_Pharma +
, http://dbpedia.org/resource/COVID-19_pandemic +
, http://dbpedia.org/resource/Phases_of_clinical_research +
, http://dbpedia.org/resource/Category:Vaccine_producers +
, http://dbpedia.org/resource/Privately_held_company +
, http://dbpedia.org/resource/Quebec +
, http://dbpedia.org/resource/Antibody +
, http://dbpedia.org/resource/COVID-19 +
|
| http://dbpedia.org/property/foundation
|
1999
|
| http://dbpedia.org/property/homepage
|
https://medicago.com/en/%7Cmedicago.com +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Toshifumi Tada
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Quebec +
, http://dbpedia.org/resource/Canada +
, http://dbpedia.org/resource/Quebec_City +
|
| http://dbpedia.org/property/logo
|
250
|
| http://dbpedia.org/property/name
|
Medicago Inc.
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Privately_held_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:Use_Canadian_English +
, http://dbpedia.org/resource/Template:Further +
, http://dbpedia.org/resource/Template:Advert +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Main_article +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:About +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:COVID-19_vaccine_producers +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Vaccine_producers +
, http://dbpedia.org/resource/Category:Privately_held_companies_of_Canada +
, http://dbpedia.org/resource/Category:Companies_based_in_Quebec_City +
, http://dbpedia.org/resource/Category:Canadian_companies_established_in_1999 +
, http://dbpedia.org/resource/Category:Specialty_drugs +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Canada +
, http://dbpedia.org/resource/Category:1999_establishments_in_Quebec +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Medicago_Inc.?oldid=1122236180&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Nicotiana_benthamiana_leaf.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Nicotiana_benthamiana_plant.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Medicago_logo.svg +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://medicago.com/en/%7Cmedicago.com +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Medicago_Inc. +
|
| http://xmlns.com/foaf/0.1/name
|
Medicago Inc.
|
| owl:sameAs |
http://dbpedia.org/resource/Medicago_Inc. +
, https://global.dbpedia.org/id/2oSGY +
, http://www.wikidata.org/entity/Q30283010 +
, http://cs.dbpedia.org/resource/Medicago_%28spole%C4%8Dnost%29 +
, http://id.dbpedia.org/resource/Medicago_Inc. +
, http://fr.dbpedia.org/resource/Medicago_%28entreprise%29 +
|
| rdf:type |
http://dbpedia.org/ontology/Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Organisation +
|
| rdfs:comment |
Medicago est une société biopharmaceutique … Medicago est une société biopharmaceutique basée à Québec qui se concentre sur la découverte, le développement et la commercialisation des particules pseudo-virales utilisant le Nicotiana benthamiana, comme bioréacteur pour produire des protéines comme vaccins et médicaments candidats. Medicago a été acquise par la société japonaise (en) en 2013.ise par la société japonaise (en) en 2013.
, Medicago Inc. je soukromá kanadská biotech … Medicago Inc. je soukromá kanadská biotechnologická firma, založená v roce 1999. Zaměřuje se na výzkum, vývoj a komerční nasazení částic podobných virům za využití rostlin jako bioreaktorů. Účelem je produkce bílkovin pro vakcíny a léčiva. Cílem společnosti je tvorba technologie pro rychlou a vysokovýtěžnou produkci svých kandidátních účinných látek; za tímto účelem používají australskou rostlinu , blízce příbuznou tabáku. Hlavními medicínskými cíli jsou antivirové vakcíny a léky založené na protilátkách. Firma vyvíjí vakcínu Medicago-GlaxoSmithKline proti covidu-19 (CoVLP).o-GlaxoSmithKline proti covidu-19 (CoVLP).
, Medicago Inc. adalah sebuah perusahaan bio … Medicago Inc. adalah sebuah perusahaan bioteknologi Kanada yang berfokus pada penemuan, pengembangan dan komersialisasi partikel- menggunakan tumbuhan sebagai "bioreaktor" untuk menghasilkan protein sebagai kandidat vaksin dan medikasi. Medicago menumbuhkan partikel-partikel mirip virusnya pada rumput Australia, .el mirip virusnya pada rumput Australia, .
, Medicago Inc. is a privately-owned Canadia … Medicago Inc. is a privately-owned Canadian biotechnology company focused on the discovery, development, and commercialization of virus-like particles using plants as bioreactors to produce proteins, candidate vaccines, and medications. By using live plant leaves as hosts in the discovery and manufacturing process, the Medicago "Proficia" technology has the goal to create a rapid, high-yield system for its product candidates.h-yield system for its product candidates.
|
| rdfs:label |
Medicago (entreprise)
, Medicago (společnost)
, Medicago Inc.
|
